Sponsor pipeline

The First Affiliated Hospital with Nanjing Medical University clinical trial pipeline

Get alerts when The First Affiliated Hospital with Nanjing Medical University's trials change

253 active trials 135 recruiting 13 Phase 3 47 disease areas 27 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-24
Primary completion pushed: 2028-07-30 → 2029-01-31
Primary endpoint(s) modified
Recruitment opened
Enrollment increased: 306 → 372 participants
Interventions modified
Completion moved earlier: 2029-08-31 → 2029-05-31
NCT07668323 Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion · Phase 3
2026-09-04
Primary endpoint(s) modified
NCT07377981 Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine… · Phase 4
2026-09-29
Recruitment opened
Trial started: 2026-09-21 (last estimated 2026-09-01)
NCT07783464 Heart Rate Variability Changes and Postoperative Delirium After Major Abdominal Surgery
2026-09-29
Recruitment opened
Primary completion pushed: 2029-07-10 → 2029-09-20
Interventions modified
NCT07698366 Breast Ultrasound Screening in Elderly Women: A Multicenter Cluster Randomized Trial
2026-09-26
Trial completed
Primary completion confirmed: August 2026 (last estimated December 2026)
NCT06557135 Brachial Versus Femoral Access for Carotid Artery Stenting
2026-09-03
Trial completed
Primary completion 2026-08-30, at least 365 days after the final estimate of 2025-08-30
Final enrollment: 29 participants (planned 35)
NCT05900882 SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With… · Phase 2
2026-09-19
Completed without a posted recruiting period
Final enrollment: 147 participants (planned 170)
Primary completion confirmed: July 2026 (last estimated December 2026)
NCT07351474 Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing…
2026-09-03
Trial completed
Primary completion 2026-07-01, at least 365 days after the final estimate of 2025-07-01
Final enrollment: 100 participants (planned 200)
NCT06700863 Screening of Biomarkers and Related Mechanisms for RIX
2026-09-06
Trial status changed: Recruiting → Unknown
NCT06569459 Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment… · Phase 2
2026-09-06
Trial status changed: Not Yet Recruiting → Unknown
NCT06564298 A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line… · Phase 2
2026-09-06
Trial status changed: Recruiting → Unknown
NCT07092111 Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer
2026-09-06
Trial status changed: Active, Not Recruiting → Unknown
NCT06565923 Study on the Staging and Prognosis Model of Bladder Cancer

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-01 NCT07852416 Electronic PHES vs Paper-based PHES for Hepatic Encephalopathy Not Yet Recruiting
2026-09-30 NCT07848633 HER2-positive Breast Cancer Without Intravenous Neoadjuvant Therapy Phase 2 Not Yet Recruiting
2026-09-29 NCT07847710 Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus… Phase 2 Recruiting
2026-09-21 NCT07831330 Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for… Phase 2 Not Yet Recruiting
2026-09-09 NCT07809698 CT-AI Breast Cancer Opportunistic Screening Health Examination Study Not Yet Recruiting
2026-09-08 NCT07806084 Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting… Not Yet Recruiting
2026-09-02 NCT07799649 ctDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPR Not Yet Recruiting
2026-09-02 NCT07800819 Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract… Not Yet Recruiting

Active trials by phase

Early Phase 1
11
Phase 1
8
Phase 1/2
5
Phase 2
83
Phase 3
13
Phase 4
10
Not charted: 123 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 253

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06929962 VA Dual Sequential Therapy Helicobacter Pylori Infection Recruiting 2026-09-01
NCT07558863 Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes Type 2 Diabetes Recruiting 2026-04-30
NCT07232095 7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy Helicobacter Pylori Recruiting 2026-04-08
NCT05410925 Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation… ST Elevation Myocardial Infarction Recruiting 2024-10-28
NCT06461377 The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy Type 2 Diabetes Recruiting 2024-06-21
NCT05461820 Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease Graves Disease Recruiting 2023-12-11
NCT07377981 Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine… Dexmedetomidine Not Yet Recruiting 2026-09-03
NCT07589699 Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP Breast Cancer Not Yet Recruiting 2026-05-15
NCT06779318 Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected… Pancreatic Cancer Not Yet Recruiting 2025-04-03
NCT06532682 Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes Diabetic Kidney Disease Active, Not Recruiting 2024-08-01
Phase 3
NCT07668323 Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion Medium Vessel Occlusion Recruiting 2026-09-23
NCT06759636 A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared… CTIT: Cancer Therapy Induced Thrombocytopenia Recruiting 2026-04-14
NCT05613478 Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of… Hepatocellular Carcinoma Recruiting 2024-12-31
NCT06563869 Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal… Esophageal Squamous Cell Carcinoma Recruiting 2024-08-21
NCT06350825 Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC… Metastatic Prostate Cancer Recruiting 2024-04-05
NCT06177015 Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC Metastatic Prostate Cancer Recruiting 2023-12-26
NCT05983783 Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide… Metastatic Prostate Cancer Recruiting 2023-08-09
NCT05956639 Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in… Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Recruiting 2023-07-21
NCT05931263 A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for… Newly Diagnosed Peripheral T-cell Lymphoma Recruiting 2023-07-05
NCT07331454 Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer Gastric Cancer (GC) Not Yet Recruiting 2026-01-12
NCT06939439 Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer Gastric Cancer Stage III Active, Not Recruiting 2025-07-01
NCT06895460 A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With… Bronchial Asthma Not Yet Recruiting 2025-06-05
NCT06953739 A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage… NK-T-Cell Lymphoma, Extranodal Not Yet Recruiting 2025-05-01
Phase 2
NCT07847710 Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus… Intrahepatic Cholangiocarcinoma (Icc) Recruiting 2026-09-29
NCT07438106 A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as… Locally Advanced Pancreatic Cancer With KRAS G12D Mutation Recruiting 2026-08-12
See all 253 active The First Affiliated Hospital with Nanjing Medical University trials with filters →

Disease areas by active trials, top 10 of 47

Breast Cancer (33) · Gastric Cancer (23) · Non-Hodgkin Lymphoma (14) · Colorectal Cancer (11) · DLBCL (9) · Esophageal Cancer (9) · Heart Failure (7) · Leukemia (7) · Prostate Cancer (7) · Cholangiocarcinoma (6)

Get alerts when The First Affiliated Hospital with Nanjing Medical University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free